{
"info": {
"nct_id": "NCT01094548",
"official_title": "A Randomized, Open-label, Phase II Study With Stimuvax® (L-BLP25 or BLP25 Liposome Vaccine) in Subjects With Either Chemotherapy-naïve, Slowly Progressive, Asymptomatic Multiple Myeloma or With Stage II/III Multiple Myeloma in Stable Response/Plateau Phase Following Anti-tumor Therapy",
"inclusion_criteria": "* Documented previously untreated, Mucinous glycoprotein 1 (MUC1)-expressing, slowly progressive asymptomatic multiple myeloma with an increasing M-protein concentration displayed on two occasions separated by an interval of at least 4 weeks within the last 18 months, or\n* Documented MUC1-expressing stage II or III multiple myeloma with a treatment-free interval of at least 3 months following prior anti-tumor therapy, and fulfilling criteria for having a stable response/plateau phase\n* Signed written informed consent\n* MUC1-expressing myeloma cells in the bone marrow\n* Greater than or equal to (>=) 18 years of age\n* Life expectancy of at least 6 months\n* Eastern Cooperative Oncology Group (ECOG) performance status of less than or equal to (<=) 1 at study entry\n* Effective contraception for both male and female subjects, if the possibility of conception exists\n* A platelet count >=100 x 10^9/Liter, white blood cells >=2.5 x 10^9/Liter, and hemoglobin >=90 gram per liter (g/L)\n* Total bilirubin <= 1.5 x upper reference range\n* Aspartate aminotransferase (AST) <= 2.5 x upper reference range\n* Serum creatinine <= 2 x upper reference\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
"exclusion_criteria": "Pre-Therapies:\n\n* Previous exposure to MUC1 targeting therapy\n* Radiotherapy or any investigational drug in the 30 days before the start of treatment in this study\n* Receipt of immunotherapy (Example: interferons, tumor necrosis factor [TNF], interleukins, or biological response modifiers [granulocyte macrophage colony stimulating factor {GM-CSF}, granulocyte colony stimulating factor {G-CSF}, macrophage-colony stimulating factor {M-CSF}], monoclonal antibodies) within 4 weeks (28 days) prior to randomization\n* Any preexisting medical condition requiring chronic oral or intravenous steroid or immunosuppressive therapy except for maintenance doses of prednisone of <=10 milligram per day (mg/day)\n\nMedical Conditions:\n\n* Autoimmune disease that in the opinion of the investigator could compromise the safety of the subject in this study\n* Hereditary or congenital immunodeficiencies\n* Known hypersensitivity reaction to any of the components of study treatments\n* Clinically significant cardiac disease, Example: New York Heart Association (NYHA) classes III-IV; unstable angina, uncontrolled arrhythmia or uncontrolled hypertension, myocardial infarction in the previous 6 months\n* Other previous malignancies within 5 years, with exception of a history of a previous basal cell carcinoma of the skin, carcinoma in situ of uterine cervix, gastrointestinal intramucosal carcinoma\n* Known Hepatitis B and/or C\n* Splenectomy\n\nStandard Safety:\n\n* Known alcohol or drug abuse\n* Medical or psychological conditions that would not permit the subject to complete the study or sign informed consent\n* Significant disease which, in the investigator's opinion, would exclude the subject from the study\n* Pregnant or breast-feeding women, women of childbearing potential, unless using effective contraception as determined by the investigator. Subjects whom the investigator considers may be at risk of pregnancy will have a pregnancy test performed per institutional standard\n* Participation in another clinical study within the past 30 days\n* Legal incapacity or limited legal capacity\n* Concurrent treatment with a non-permitted drug\n* Any other reason that, in the opinion of the investigator, precludes the subject from participating in the study",
"miscellaneous_criteria": ""
},
"inclusion_lines": [
{
"identified_line": {
"line": "* Documented previously untreated, Mucinous glycoprotein 1 (MUC1)-expressing, slowly progressive asymptomatic multiple myeloma with an increasing M-protein concentration displayed on two occasions separated by an interval of at least 4 weeks within the last 18 months, or",
"criterions": [
{
"exact_snippets": "Documented previously untreated",
"criterion": "treatment history",
"requirement": {
"requirement_type": "status",
"expected_value": "untreated"
}
},
{
"exact_snippets": "Mucinous glycoprotein 1 (MUC1)-expressing",
"criterion": "MUC1 expression",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
},
{
"exact_snippets": "slowly progressive asymptomatic multiple myeloma",
"criterion": "multiple myeloma",
"requirement": {
"requirement_type": "progression",
"expected_value": "slowly progressive"
}
},
{
"exact_snippets": "slowly progressive asymptomatic multiple myeloma",
"criterion": "multiple myeloma",
"requirement": {
"requirement_type": "symptoms",
"expected_value": "asymptomatic"
}
},
{
"exact_snippets": "increasing M-protein concentration displayed on two occasions separated by an interval of at least 4 weeks within the last 18 months",
"criterion": "M-protein concentration",
"requirement": {
"requirement_type": "trend",
"expected_value": "increasing"
}
},
{
"exact_snippets": "increasing M-protein concentration displayed on two occasions separated by an interval of at least 4 weeks within the last 18 months",
"criterion": "M-protein concentration",
"requirement": {
"requirement_type": "measurement frequency",
"expected_value": "two occasions separated by an interval of at least 4 weeks within the last 18 months"
}
}
]
},
"logical_structure": {
"or_criteria": [
{
"and_criteria": [
{
"exact_snippets": "Documented previously untreated",
"criterion": "treatment history",
"requirement": {
"requirement_type": "status",
"expected_value": "untreated"
}
},
{
"exact_snippets": "Mucinous glycoprotein 1 (MUC1)-expressing",
"criterion": "MUC1 expression",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
},
{
"and_criteria": [
{
"exact_snippets": "slowly progressive asymptomatic multiple myeloma",
"criterion": "multiple myeloma",
"requirement": {
"requirement_type": "progression",
"expected_value": "slowly progressive"
}
},
{
"exact_snippets": "slowly progressive asymptomatic multiple myeloma",
"criterion": "multiple myeloma",
"requirement": {
"requirement_type": "symptoms",
"expected_value": "asymptomatic"
}
}
]
},
{
"and_criteria": [
{
"exact_snippets": "increasing M-protein concentration displayed on two occasions separated by an interval of at least 4 weeks within the last 18 months",
"criterion": "M-protein concentration",
"requirement": {
"requirement_type": "trend",
"expected_value": "increasing"
}
},
{
"exact_snippets": "increasing M-protein concentration displayed on two occasions separated by an interval of at least 4 weeks within the last 18 months",
"criterion": "M-protein concentration",
"requirement": {
"requirement_type": "measurement frequency",
"expected_value": "two occasions separated by an interval of at least 4 weeks within the last 18 months"
}
}
]
}
]
}
]
}
},
{
"identified_line": {
"line": "* Signed written informed consent",
"criterions": [
{
"exact_snippets": "Signed written informed consent",
"criterion": "informed consent",
"requirement": {
"requirement_type": "signed",
"expected_value": true
}
},
{
"exact_snippets": "Signed written informed consent",
"criterion": "informed consent",
"requirement": {
"requirement_type": "format",
"expected_value": "written"
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "Signed written informed consent",
"criterion": "informed consent",
"requirement": {
"requirement_type": "signed",
"expected_value": true
}
},
{
"exact_snippets": "Signed written informed consent",
"criterion": "informed consent",
"requirement": {
"requirement_type": "format",
"expected_value": "written"
}
}
]
}
},
{
"identified_line": {
"line": "* MUC1-expressing myeloma cells in the bone marrow",
"criterions": [
{
"exact_snippets": "MUC1-expressing myeloma cells",
"criterion": "MUC1 expression in myeloma cells",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
},
{
"exact_snippets": "myeloma cells in the bone marrow",
"criterion": "myeloma cells in the bone marrow",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "MUC1-expressing myeloma cells",
"criterion": "MUC1 expression in myeloma cells",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
},
{
"exact_snippets": "myeloma cells in the bone marrow",
"criterion": "myeloma cells in the bone marrow",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
}
]
}
},
{
"identified_line": {
"line": "* Greater than or equal to (>=) 18 years of age",
"criterions": [
{
"exact_snippets": "Greater than or equal to (>=) 18 years of age",
"criterion": "age",
"requirement": {
"requirement_type": "value",
"expected_value": {
"operator": ">=",
"value": 18,
"unit": "years"
}
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "Greater than or equal to (>=) 18 years of age",
"criterion": "age",
"requirement": {
"requirement_type": "value",
"expected_value": {
"operator": ">=",
"value": 18,
"unit": "years"
}
}
}
]
}
},
{
"identified_line": {
"line": "* Life expectancy of at least 6 months",
"criterions": [
{
"exact_snippets": "Life expectancy of at least 6 months",
"criterion": "life expectancy",
"requirement": {
"requirement_type": "duration",
"expected_value": {
"operator": ">=",
"value": 6,
"unit": "months"
}
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "Life expectancy of at least 6 months",
"criterion": "life expectancy",
"requirement": {
"requirement_type": "duration",
"expected_value": {
"operator": ">=",
"value": 6,
"unit": "months"
}
}
}
]
}
},
{
"identified_line": {
"line": "* Eastern Cooperative Oncology Group (ECOG) performance status of less than or equal to (<=) 1 at study entry",
"criterions": [
{
"exact_snippets": "Eastern Cooperative Oncology Group (ECOG) performance status of less than or equal to (<=) 1",
"criterion": "ECOG performance status",
"requirement": {
"requirement_type": "value",
"expected_value": {
"operator": "<=",
"value": 1,
"unit": "N/A"
}
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "Eastern Cooperative Oncology Group (ECOG) performance status of less than or equal to (<=) 1",
"criterion": "ECOG performance status",
"requirement": {
"requirement_type": "value",
"expected_value": {
"operator": "<=",
"value": 1,
"unit": "N/A"
}
}
}
]
}
},
{
"identified_line": {
"line": "* Effective contraception for both male and female subjects, if the possibility of conception exists",
"criterions": [
{
"exact_snippets": "Effective contraception for both male and female subjects",
"criterion": "contraception",
"requirement": {
"requirement_type": "effectiveness",
"expected_value": true
}
},
{
"exact_snippets": "if the possibility of conception exists",
"criterion": "possibility of conception",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
}
]
},
"logical_structure": {
"condition": {
"exact_snippets": "if the possibility of conception exists",
"criterion": "possibility of conception",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
},
"then_criteria": {
"exact_snippets": "Effective contraception for both male and female subjects",
"criterion": "contraception",
"requirement": {
"requirement_type": "effectiveness",
"expected_value": true
}
},
"else_criteria": null
}
},
{
"identified_line": {
"line": "* A platelet count >=100 x 10^9/Liter, white blood cells >=2.5 x 10^9/Liter, and hemoglobin >=90 gram per liter (g/L)",
"criterions": [
{
"exact_snippets": "platelet count >=100 x 10^9/Liter",
"criterion": "platelet count",
"requirement": {
"requirement_type": "quantity",
"expected_value": {
"operator": ">=",
"value": 100,
"unit": "x 10^9/Liter"
}
}
},
{
"exact_snippets": "white blood cells >=2.5 x 10^9/Liter",
"criterion": "white blood cells",
"requirement": {
"requirement_type": "quantity",
"expected_value": {
"operator": ">=",
"value": 2.5,
"unit": "x 10^9/Liter"
}
}
},
{
"exact_snippets": "hemoglobin >=90 gram per liter (g/L)",
"criterion": "hemoglobin",
"requirement": {
"requirement_type": "quantity",
"expected_value": {
"operator": ">=",
"value": 90,
"unit": "gram per liter (g/L)"
}
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "platelet count >=100 x 10^9/Liter",
"criterion": "platelet count",
"requirement": {
"requirement_type": "quantity",
"expected_value": {
"operator": ">=",
"value": 100,
"unit": "x 10^9/Liter"
}
}
},
{
"exact_snippets": "white blood cells >=2.5 x 10^9/Liter",
"criterion": "white blood cells",
"requirement": {
"requirement_type": "quantity",
"expected_value": {
"operator": ">=",
"value": 2.5,
"unit": "x 10^9/Liter"
}
}
},
{
"exact_snippets": "hemoglobin >=90 gram per liter (g/L)",
"criterion": "hemoglobin",
"requirement": {
"requirement_type": "quantity",
"expected_value": {
"operator": ">=",
"value": 90,
"unit": "gram per liter (g/L)"
}
}
}
]
}
},
{
"identified_line": {
"line": "* Total bilirubin <= 1.5 x upper reference range",
"criterions": [
{
"exact_snippets": "Total bilirubin <= 1.5 x upper reference range",
"criterion": "total bilirubin",
"requirement": {
"requirement_type": "level",
"expected_value": {
"operator": "<=",
"value": 1.5,
"unit": "x upper reference range"
}
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "Total bilirubin <= 1.5 x upper reference range",
"criterion": "total bilirubin",
"requirement": {
"requirement_type": "level",
"expected_value": {
"operator": "<=",
"value": 1.5,
"unit": "x upper reference range"
}
}
}
]
}
},
{
"identified_line": {
"line": "* Aspartate aminotransferase (AST) <= 2.5 x upper reference range",
"criterions": [
{
"exact_snippets": "Aspartate aminotransferase (AST) <= 2.5 x upper reference range",
"criterion": "Aspartate aminotransferase (AST)",
"requirement": {
"requirement_type": "level",
"expected_value": {
"operator": "<=",
"value": 2.5,
"unit": "x upper reference range"
}
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "Aspartate aminotransferase (AST) <= 2.5 x upper reference range",
"criterion": "Aspartate aminotransferase (AST)",
"requirement": {
"requirement_type": "level",
"expected_value": {
"operator": "<=",
"value": 2.5,
"unit": "x upper reference range"
}
}
}
]
}
},
{
"identified_line": {
"line": "* Serum creatinine <= 2 x upper reference",
"criterions": [
{
"exact_snippets": "Serum creatinine <= 2 x upper reference",
"criterion": "serum creatinine",
"requirement": {
"requirement_type": "level",
"expected_value": {
"operator": "<=",
"value": 2,
"unit": "x upper reference"
}
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "Serum creatinine <= 2 x upper reference",
"criterion": "serum creatinine",
"requirement": {
"requirement_type": "level",
"expected_value": {
"operator": "<=",
"value": 2,
"unit": "x upper reference"
}
}
}
]
}
},
{
"identified_line": {
"line": "Healthy volunteers allowed",
"criterions": [
{
"exact_snippets": "Healthy volunteers allowed",
"criterion": "volunteer health status",
"requirement": {
"requirement_type": "status",
"expected_value": "healthy"
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "Healthy volunteers allowed",
"criterion": "volunteer health status",
"requirement": {
"requirement_type": "status",
"expected_value": "healthy"
}
}
]
}
},
{
"identified_line": {
"line": "Must have minimum age of 18 Years",
"criterions": [
{
"exact_snippets": "minimum age of 18 Years",
"criterion": "age",
"requirement": {
"requirement_type": "minimum",
"expected_value": {
"operator": ">=",
"value": 18,
"unit": "Years"
}
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "minimum age of 18 Years",
"criterion": "age",
"requirement": {
"requirement_type": "minimum",
"expected_value": {
"operator": ">=",
"value": 18,
"unit": "Years"
}
}
}
]
}
}
],
"exclusion_lines": [
{
"identified_line": {
"line": "Pre-Therapies:",
"criterions": [
{
"exact_snippets": "Pre-Therapies",
"criterion": "pre-therapies",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
}
]
},
"logical_structure": {
"not_criteria": {
"exact_snippets": "Pre-Therapies",
"criterion": "pre-therapies",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
}
}
},
{
"identified_line": {
"line": "* Previous exposure to MUC1 targeting therapy",
"criterions": [
{
"exact_snippets": "Previous exposure to MUC1 targeting therapy",
"criterion": "MUC1 targeting therapy",
"requirement": {
"requirement_type": "exposure",
"expected_value": true
}
}
]
},
"logical_structure": {
"not_criteria": {
"exact_snippets": "Previous exposure to MUC1 targeting therapy",
"criterion": "MUC1 targeting therapy",
"requirement": {
"requirement_type": "exposure",
"expected_value": true
}
}
}
},
{
"identified_line": {
"line": "* Radiotherapy or any investigational drug in the 30 days before the start of treatment in this study",
"criterions": [
{
"exact_snippets": "Radiotherapy ... in the 30 days before the start of treatment",
"criterion": "radiotherapy",
"requirement": {
"requirement_type": "time since last treatment",
"expected_value": {
"operator": ">=",
"value": 30,
"unit": "days"
}
}
},
{
"exact_snippets": "any investigational drug in the 30 days before the start of treatment",
"criterion": "investigational drug",
"requirement": {
"requirement_type": "time since last treatment",
"expected_value": {
"operator": ">=",
"value": 30,
"unit": "days"
}
}
}
]
},
"logical_structure": {
"or_criteria": [
{
"exact_snippets": "Radiotherapy ... in the 30 days before the start of treatment",
"criterion": "radiotherapy",
"requirement": {
"requirement_type": "time since last treatment",
"expected_value": {
"operator": ">=",
"value": 30,
"unit": "days"
}
}
},
{
"exact_snippets": "any investigational drug in the 30 days before the start of treatment",
"criterion": "investigational drug",
"requirement": {
"requirement_type": "time since last treatment",
"expected_value": {
"operator": ">=",
"value": 30,
"unit": "days"
}
}
}
]
}
},
{
"identified_line": {
"line": "* Receipt of immunotherapy (Example: interferons, tumor necrosis factor [TNF], interleukins, or biological response modifiers [granulocyte macrophage colony stimulating factor {GM-CSF}, granulocyte colony stimulating factor {G-CSF}, macrophage-colony stimulating factor {M-CSF}], monoclonal antibodies) within 4 weeks (28 days) prior to randomization",
"criterions": [
{
"exact_snippets": "Receipt of immunotherapy ... within 4 weeks (28 days) prior to randomization",
"criterion": "receipt of immunotherapy",
"requirement": {
"requirement_type": "time frame",
"expected_value": {
"operator": "<=",
"value": 28,
"unit": "days"
}
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "Receipt of immunotherapy ... within 4 weeks (28 days) prior to randomization",
"criterion": "receipt of immunotherapy",
"requirement": {
"requirement_type": "time frame",
"expected_value": {
"operator": "<=",
"value": 28,
"unit": "days"
}
}
}
]
}
},
{
"identified_line": {
"line": "Medical Conditions:",
"criterions": [
{
"exact_snippets": "Medical Conditions",
"criterion": "medical conditions",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
}
]
},
"logical_structure": {
"not_criteria": {
"exact_snippets": "Medical Conditions",
"criterion": "medical conditions",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
}
}
},
{
"identified_line": {
"line": "* Autoimmune disease that in the opinion of the investigator could compromise the safety of the subject in this study",
"criterions": [
{
"exact_snippets": "Autoimmune disease ... could compromise the safety of the subject",
"criterion": "autoimmune disease",
"requirement": {
"requirement_type": "safety risk",
"expected_value": true
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "Autoimmune disease ... could compromise the safety of the subject",
"criterion": "autoimmune disease",
"requirement": {
"requirement_type": "safety risk",
"expected_value": true
}
}
]
}
},
{
"identified_line": {
"line": "* Hereditary or congenital immunodeficiencies",
"criterions": [
{
"exact_snippets": "Hereditary or congenital immunodeficiencies",
"criterion": "immunodeficiencies",
"requirement": {
"requirement_type": "type",
"expected_value": [
"hereditary",
"congenital"
]
}
}
]
},
"logical_structure": {
"not_criteria": {
"exact_snippets": "Hereditary or congenital immunodeficiencies",
"criterion": "immunodeficiencies",
"requirement": {
"requirement_type": "type",
"expected_value": [
"hereditary",
"congenital"
]
}
}
}
},
{
"identified_line": {
"line": "* Known hypersensitivity reaction to any of the components of study treatments",
"criterions": [
{
"exact_snippets": "Known hypersensitivity reaction to any of the components of study treatments",
"criterion": "hypersensitivity reaction",
"requirement": {
"requirement_type": "presence",
"expected_value": false
}
}
]
},
"logical_structure": {
"not_criteria": {
"exact_snippets": "Known hypersensitivity reaction to any of the components of study treatments",
"criterion": "hypersensitivity reaction",
"requirement": {
"requirement_type": "presence",
"expected_value": false
}
}
}
},
{
"identified_line": {
"line": "* Clinically significant cardiac disease, Example: New York Heart Association (NYHA) classes III-IV; unstable angina, uncontrolled arrhythmia or uncontrolled hypertension, myocardial infarction in the previous 6 months",
"criterions": [
{
"exact_snippets": "Clinically significant cardiac disease",
"criterion": "cardiac disease",
"requirement": {
"requirement_type": "severity",
"expected_value": "clinically significant"
}
},
{
"exact_snippets": "New York Heart Association (NYHA) classes III-IV",
"criterion": "NYHA class",
"requirement": {
"requirement_type": "classification",
"expected_value": [
"III",
"IV"
]
}
},
{
"exact_snippets": "unstable angina",
"criterion": "angina",
"requirement": {
"requirement_type": "stability",
"expected_value": "unstable"
}
},
{
"exact_snippets": "uncontrolled arrhythmia",
"criterion": "arrhythmia",
"requirement": {
"requirement_type": "control",
"expected_value": "uncontrolled"
}
},
{
"exact_snippets": "uncontrolled hypertension",
"criterion": "hypertension",
"requirement": {
"requirement_type": "control",
"expected_value": "uncontrolled"
}
},
{
"exact_snippets": "myocardial infarction in the previous 6 months",
"criterion": "myocardial infarction",
"requirement": {
"requirement_type": "time since event",
"expected_value": {
"operator": "<=",
"value": 6,
"unit": "months"
}
}
}
]
},
"logical_structure": {
"or_criteria": [
{
"and_criteria": [
{
"exact_snippets": "Clinically significant cardiac disease",
"criterion": "cardiac disease",
"requirement": {
"requirement_type": "severity",
"expected_value": "clinically significant"
}
},
{
"or_criteria": [
{
"exact_snippets": "New York Heart Association (NYHA) classes III-IV",
"criterion": "NYHA class",
"requirement": {
"requirement_type": "classification",
"expected_value": [
"III",
"IV"
]
}
},
{
"exact_snippets": "unstable angina",
"criterion": "angina",
"requirement": {
"requirement_type": "stability",
"expected_value": "unstable"
}
},
{
"exact_snippets": "uncontrolled arrhythmia",
"criterion": "arrhythmia",
"requirement": {
"requirement_type": "control",
"expected_value": "uncontrolled"
}
},
{
"exact_snippets": "uncontrolled hypertension",
"criterion": "hypertension",
"requirement": {
"requirement_type": "control",
"expected_value": "uncontrolled"
}
}
]
}
]
},
{
"exact_snippets": "myocardial infarction in the previous 6 months",
"criterion": "myocardial infarction",
"requirement": {
"requirement_type": "time since event",
"expected_value": {
"operator": "<=",
"value": 6,
"unit": "months"
}
}
}
]
}
},
{
"identified_line": {
"line": "* Other previous malignancies within 5 years, with exception of a history of a previous basal cell carcinoma of the skin, carcinoma in situ of uterine cervix, gastrointestinal intramucosal carcinoma",
"criterions": [
{
"exact_snippets": "Other previous malignancies within 5 years",
"criterion": "previous malignancies",
"requirement": {
"requirement_type": "time frame",
"expected_value": {
"operator": "<=",
"value": 5,
"unit": "years"
}
}
},
{
"exact_snippets": "exception of a history of a previous basal cell carcinoma of the skin",
"criterion": "basal cell carcinoma of the skin",
"requirement": {
"requirement_type": "history",
"expected_value": true
}
},
{
"exact_snippets": "exception of a history of a ... carcinoma in situ of uterine cervix",
"criterion": "carcinoma in situ of uterine cervix",
"requirement": {
"requirement_type": "history",
"expected_value": true
}
},
{
"exact_snippets": "exception of a history of a ... gastrointestinal intramucosal carcinoma",
"criterion": "gastrointestinal intramucosal carcinoma",
"requirement": {
"requirement_type": "history",
"expected_value": true
}
}
]
},
"logical_structure": {
"condition": {
"and_criteria": [
{
"exact_snippets": "Other previous malignancies within 5 years",
"criterion": "previous malignancies",
"requirement": {
"requirement_type": "time frame",
"expected_value": {
"operator": "<=",
"value": 5,
"unit": "years"
}
}
},
{
"not_criteria": {
"or_criteria": [
{
"exact_snippets": "exception of a history of a previous basal cell carcinoma of the skin",
"criterion": "basal cell carcinoma of the skin",
"requirement": {
"requirement_type": "history",
"expected_value": true
}
},
{
"exact_snippets": "exception of a history of a ... carcinoma in situ of uterine cervix",
"criterion": "carcinoma in situ of uterine cervix",
"requirement": {
"requirement_type": "history",
"expected_value": true
}
},
{
"exact_snippets": "exception of a history of a ... gastrointestinal intramucosal carcinoma",
"criterion": "gastrointestinal intramucosal carcinoma",
"requirement": {
"requirement_type": "history",
"expected_value": true
}
}
]
}
}
]
},
"then_criteria": null,
"else_criteria": null
}
},
{
"identified_line": {
"line": "* Known Hepatitis B and/or C",
"criterions": [
{
"exact_snippets": "Known Hepatitis B",
"criterion": "Hepatitis B",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
},
{
"exact_snippets": "Known ... C",
"criterion": "Hepatitis C",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
}
]
},
"logical_structure": {
"or_criteria": [
{
"exact_snippets": "Known Hepatitis B",
"criterion": "Hepatitis B",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
},
{
"exact_snippets": "Known ... C",
"criterion": "Hepatitis C",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
}
]
}
},
{
"identified_line": {
"line": "* Splenectomy",
"criterions": [
{
"exact_snippets": "Splenectomy",
"criterion": "splenectomy",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
}
]
},
"logical_structure": {
"not_criteria": {
"exact_snippets": "Splenectomy",
"criterion": "splenectomy",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
}
}
},
{
"identified_line": {
"line": "Standard Safety:",
"criterions": [
{
"exact_snippets": "Standard Safety",
"criterion": "safety",
"requirement": {
"requirement_type": "standard",
"expected_value": true
}
}
]
},
"logical_structure": {
"not_criteria": {
"exact_snippets": "Standard Safety",
"criterion": "safety",
"requirement": {
"requirement_type": "standard",
"expected_value": true
}
}
}
},
{
"identified_line": {
"line": "* Known alcohol or drug abuse",
"criterions": [
{
"exact_snippets": "Known alcohol or drug abuse",
"criterion": "alcohol abuse",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
},
{
"exact_snippets": "Known alcohol or drug abuse",
"criterion": "drug abuse",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
}
]
},
"logical_structure": {
"or_criteria": [
{
"exact_snippets": "Known alcohol or drug abuse",
"criterion": "alcohol abuse",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
},
{
"exact_snippets": "Known alcohol or drug abuse",
"criterion": "drug abuse",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
}
]
}
},
{
"identified_line": {
"line": "* Medical or psychological conditions that would not permit the subject to complete the study or sign informed consent",
"criterions": [
{
"exact_snippets": "Medical ... conditions that would not permit the subject to complete the study or sign informed consent",
"criterion": "medical conditions",
"requirement": {
"requirement_type": "impact on study participation",
"expected_value": "would not permit completion or signing consent"
}
},
{
"exact_snippets": "psychological conditions that would not permit the subject to complete the study or sign informed consent",
"criterion": "psychological conditions",
"requirement": {
"requirement_type": "impact on study participation",
"expected_value": "would not permit completion or signing consent"
}
}
]
},
"logical_structure": {
"or_criteria": [
{
"exact_snippets": "Medical ... conditions that would not permit the subject to complete the study or sign informed consent",
"criterion": "medical conditions",
"requirement": {
"requirement_type": "impact on study participation",
"expected_value": "would not permit completion or signing consent"
}
},
{
"exact_snippets": "psychological conditions that would not permit the subject to complete the study or sign informed consent",
"criterion": "psychological conditions",
"requirement": {
"requirement_type": "impact on study participation",
"expected_value": "would not permit completion or signing consent"
}
}
]
}
},
{
"identified_line": {
"line": "* Significant disease which, in the investigator's opinion, would exclude the subject from the study",
"criterions": [
{
"exact_snippets": "Significant disease ... would exclude the subject from the study",
"criterion": "significant disease",
"requirement": {
"requirement_type": "exclusion",
"expected_value": true
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "Significant disease ... would exclude the subject from the study",
"criterion": "significant disease",
"requirement": {
"requirement_type": "exclusion",
"expected_value": true
}
}
]
}
},
{
"identified_line": {
"line": "* Pregnant or breast-feeding women, women of childbearing potential, unless using effective contraception as determined by the investigator. Subjects whom the investigator considers may be at risk of pregnancy will have a pregnancy test performed per institutional standard",
"criterions": [
{
"exact_snippets": "Pregnant or breast-feeding women",
"criterion": "pregnancy status",
"requirement": {
"requirement_type": "status",
"expected_value": "not pregnant or breast-feeding"
}
},
{
"exact_snippets": "women of childbearing potential, unless using effective contraception",
"criterion": "contraception use",
"requirement": {
"requirement_type": "use",
"expected_value": true
}
},
{
"exact_snippets": "Subjects whom the investigator considers may be at risk of pregnancy will have a pregnancy test performed",
"criterion": "risk of pregnancy",
"requirement": {
"requirement_type": "risk assessment",
"expected_value": "as determined by the investigator"
}
}
]
},
"logical_structure": {
"or_criteria": [
{
"and_criteria": [
{
"exact_snippets": "Pregnant or breast-feeding women",
"criterion": "pregnancy status",
"requirement": {
"requirement_type": "status",
"expected_value": "not pregnant or breast-feeding"
}
},
{
"exact_snippets": "women of childbearing potential, unless using effective contraception",
"criterion": "contraception use",
"requirement": {
"requirement_type": "use",
"expected_value": true
}
}
]
},
{
"exact_snippets": "Subjects whom the investigator considers may be at risk of pregnancy will have a pregnancy test performed",
"criterion": "risk of pregnancy",
"requirement": {
"requirement_type": "risk assessment",
"expected_value": "as determined by the investigator"
}
}
]
}
},
{
"identified_line": {
"line": "* Participation in another clinical study within the past 30 days",
"criterions": [
{
"exact_snippets": "Participation in another clinical study within the past 30 days",
"criterion": "participation in another clinical study",
"requirement": {
"requirement_type": "time frame",
"expected_value": {
"operator": "<=",
"value": 30,
"unit": "days"
}
}
}
]
},
"logical_structure": {
"not_criteria": {
"exact_snippets": "Participation in another clinical study within the past 30 days",
"criterion": "participation in another clinical study",
"requirement": {
"requirement_type": "time frame",
"expected_value": {
"operator": "<=",
"value": 30,
"unit": "days"
}
}
}
}
},
{
"identified_line": {
"line": "* Legal incapacity or limited legal capacity",
"criterions": [
{
"exact_snippets": "Legal incapacity",
"criterion": "legal capacity",
"requirement": {
"requirement_type": "status",
"expected_value": "incapacity"
}
},
{
"exact_snippets": "limited legal capacity",
"criterion": "legal capacity",
"requirement": {
"requirement_type": "status",
"expected_value": "limited"
}
}
]
},
"logical_structure": {
"or_criteria": [
{
"exact_snippets": "Legal incapacity",
"criterion": "legal capacity",
"requirement": {
"requirement_type": "status",
"expected_value": "incapacity"
}
},
{
"exact_snippets": "limited legal capacity",
"criterion": "legal capacity",
"requirement": {
"requirement_type": "status",
"expected_value": "limited"
}
}
]
}
},
{
"identified_line": {
"line": "* Concurrent treatment with a non-permitted drug",
"criterions": [
{
"exact_snippets": "Concurrent treatment with a non-permitted drug",
"criterion": "concurrent treatment",
"requirement": {
"requirement_type": "drug type",
"expected_value": "non-permitted"
}
}
]
},
"logical_structure": {
"not_criteria": {
"exact_snippets": "Concurrent treatment with a non-permitted drug",
"criterion": "concurrent treatment",
"requirement": {
"requirement_type": "drug type",
"expected_value": "non-permitted"
}
}
}
},
{
"identified_line": {
"line": "* Any other reason that, in the opinion of the investigator, precludes the subject from participating in the study",
"criterions": [
{
"exact_snippets": "Any other reason that, in the opinion of the investigator, precludes the subject from participating in the study",
"criterion": "investigator's opinion",
"requirement": {
"requirement_type": "preclusion",
"expected_value": true
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "Any other reason that, in the opinion of the investigator, precludes the subject from participating in the study",
"criterion": "investigator's opinion",
"requirement": {
"requirement_type": "preclusion",
"expected_value": true
}
}
]
}
}
],
"miscellaneous_lines": [],
"failed_inclusion": [
{
"identified_line": {
"line": "* Documented MUC1-expressing stage II or III multiple myeloma with a treatment-free interval of at least 3 months following prior anti-tumor therapy, and fulfilling criteria for having a stable response/plateau phase",
"criterions": [
{
"exact_snippets": "Documented MUC1-expressing",
"criterion": "MUC1 expression",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
},
{
"exact_snippets": "stage II or III multiple myeloma",
"criterion": "multiple myeloma stage",
"requirement": {
"requirement_type": "stage",
"expected_value": [
"II",
"III"
]
}
},
{
"exact_snippets": "treatment-free interval of at least 3 months following prior anti-tumor therapy",
"criterion": "treatment-free interval",
"requirement": {
"requirement_type": "duration",
"expected_value": {
"operator": ">=",
"value": 3,
"unit": "months"
}
}
},
{
"exact_snippets": "fulfilling criteria for having a stable response/plateau phase",
"criterion": "response phase",
"requirement": {
"requirement_type": "stability",
"expected_value": "stable response/plateau phase"
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"and_criteria": [
{
"exact_snippets": "Documented MUC1-expressing",
"criterion": "MUC1 expression",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
},
{
"or_criteria": [
{
"exact_snippets": "stage II or III multiple myeloma",
"criterion": "multiple myeloma stage",
"requirement": {
"requirement_type": "stage",
"expected_value": [
"II"
]
}
},
{
"exact_snippets": "stage II or III multiple myeloma",
"criterion": "multiple myeloma stage",
"requirement": {
"requirement_type": "stage",
"expected_value": [
"III"
]
}
}
]
}
]
},
{
"exact_snippets": "treatment-free interval of at least 3 months following prior anti-tumor therapy",
"criterion": "treatment-free interval",
"requirement": {
"requirement_type": "duration",
"expected_value": {
"operator": ">=",
"value": 3,
"unit": "months"
}
}
},
{
"exact_snippets": "fulfilling criteria for having a stable response/plateau phase",
"criterion": "response phase",
"requirement": {
"requirement_type": "stability",
"expected_value": "stable response/plateau phase"
}
}
]
}
}
],
"failed_exclusion": [
{
"identified_line": {
"line": "* Any preexisting medical condition requiring chronic oral or intravenous steroid or immunosuppressive therapy except for maintenance doses of prednisone of <=10 milligram per day (mg/day)",
"criterions": [
{
"exact_snippets": "preexisting medical condition requiring chronic oral or intravenous steroid or immunosuppressive therapy",
"criterion": "preexisting medical condition requiring chronic steroid or immunosuppressive therapy",
"requirement": {
"requirement_type": "presence",
"expected_value": false
}
},
{
"exact_snippets": "maintenance doses of prednisone of <=10 milligram per day (mg/day)",
"criterion": "maintenance dose of prednisone",
"requirement": {
"requirement_type": "dosage",
"expected_value": {
"operator": "<=",
"value": 10,
"unit": "mg/day"
}
}
}
]
},
"logical_structure": {
"condition": {
"and_criteria": [
{
"exact_snippets": "preexisting medical condition requiring chronic oral or intravenous steroid or immunosuppressive therapy",
"criterion": "preexisting medical condition requiring chronic steroid or immunosuppressive therapy",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
},
{
"exact_snippets": "maintenance doses of prednisone of <=10 milligram per day (mg/day)",
"criterion": "maintenance dose of prednisone",
"requirement": {
"requirement_type": "dosage",
"expected_value": {
"operator": "<=",
"value": 10,
"unit": "mg/day"
}
}
}
]
},
"then_criteria": null,
"else_criteria": {
"exact_snippets": "preexisting medical condition requiring chronic oral or intravenous steroid or immunosuppressive therapy",
"criterion": "preexisting medical condition requiring chronic steroid or immunosuppressive therapy",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
}
}
}
],
"failed_miscellaneous": []
}